Loading…
← CockpitCompetitor Analysis › 2666.HK Genertec Universal Medical Group Company LimitedOpen in the cockpit ↗

Genertec Universal Medical Group Company Limited2666.HKCompetitor analysis, valuation and peers

Hong Kong · HKD·Financials›Finance/Rental/Leasing

Beijing-based group offering medical-equipment finance leasing plus hospital operation and healthcare-digitalization services.

≈ A Chinese hybrid of GE Healthcare financial services and a hospital operatorMomentum strong 68
Mkt cap
$1.18B
US dollars, full cap
Free float
46%
of shares outstanding
$/day
$3.25M
20-day average traded
P/B
0.40×
price to book
ROE
11.6%
delivered
Implied ROE
5.2%
what the price asks
Next earnings
133 days
31 Mar 2027
Close · HKDHK$4.60
1D-0.7%
1W-1.4%
1M+1.3%
3M+0.2%
6M-16.1%
YTD-22.7%
1Y-29.6%
ATR %1.8%
52w lowhigh31.0% off high

What Genertec Universal Medical does

Beijing-based group offering medical-equipment finance leasing plus hospital operation and healthcare-digitalization services.

Earns interest-style income on leases and loans extended to hospitals buying equipment, and fees from running hospitals it owns or manages, so growth depends on hospitals' ability to repay. Its parent, China Genertec Group, is a central state-owned enterprise.

In one line: A Chinese hybrid of GE Healthcare financial services and a hospital operator.

Products and services

  • Medical equipment finance leasing
  • Hospital operations
  • Medical equipment trading
  • Medical digitalization services

Customers

  • Hospitals and healthcare providers in China

Where it sits in the supply chain

  • Financials/Healthcare
  • Medical equipment finance leasing
  • Hospital & digital-health services

What could go right

  • Hospital equipment upgrade cycle in China

What could go wrong

  • Leasing credit risk
  • Hospital reimbursement/policy risk

Moat: narrow (customer qualification, scale, distribution). Decades-long relationships financing hospital equipment purchases across China.

Headquarters: Beijing, China · Founded: 1984 · Employees: 23,791

Named competitors

Genertec Universal Medical at a glance

Size Genertec Universal Medical (2666.HK) is a Hong Kong Financials company (Finance/Rental/Leasing) with a market value of $1.18B, the 541st largest of 885 Hong Kong companies the cockpit tracks. Shares closed at HK$4.60 on 18 Nov 2026.

Performance Over six months the shares fell 16.1%, against -5.1% for the median peer and -14.0% for the Hong Kong market (cap-weighted) — 5th lowest of 21 in its peer set.

Growth Revenue fell 0.3% over the last twelve months (peer median +4.1%); the operating margin is 29.6% (peer median 25.5%).

Valuation It trades at 0.40× book value against a peer median of 1.29× (2nd cheapest of 21).

Price implies The share price implies a return on equity of about 5.2%; Genertec Universal Medical delivers 11.6%, so the price asks less than the business earns today.

Next results Next results expected around 31 Mar 2027 (exchange calendar; dates can move).

Relative performance

809010011021 May 202621 Aug 202618 Nov 2026Peer median 962666.HK 84
Six months, rebased to 100: Genertec Universal Medical against the median of its 20 peers (local-currency closes).

Genertec Universal Medical financials

Reported figures in HKD; fiscal year ends 2025-12-31. TTM = trailing twelve months.
TTMFY2025FY2024FY2023FY2022
RevenueHK$16.2BHK$16.3BHK$15.2BHK$15.4BHK$14.3B
Revenue growth—+7%-1%+8%—
Gross profitHK$6.23BHK$6.48BHK$6.89BHK$7.35BHK$7.29B
EBITDAHK$5.74BHK$5.87BHK$5.99BHK$6.66BHK$6.40B
Net incomeHK$2.46BHK$2.34BHK$2.20BHK$2.23BHK$2.20B
Free cash flowHK$1.23BHK$3.43B-HK$2.23BHK$1.98B-HK$655M
Capital expenditureHK$1.16BHK$1.07BHK$1.36BHK$991MHK$719M
Total debtn/aHK$55.8BHK$57.5BHK$55.5BHK$55.3B

Quarterly statements and history in the cockpit →

Genertec Universal Medical competitor charts

The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.

Performance: 6-month against 1-month return

-20%0%+20%-10%0%+10%+20%AIFHOMEFIRST85669678CANFINHOME9941ATLC6033006592FIVESTARSBFCAPTUSWD1905WLFC858446650086AAVAS2666.HK6-month return →1-month return →
Up and to the right = strong over both horizons. Genertec Universal Medical is the large dot.

Fundamentals: return on equity against price-to-book

0%5%10%15%20%10×20×AIFHOMEFIRST85669678CANFINHOME9941ATLC6033006592FIVESTARZIGSBFCAPTUSWD1905WLFC858446650086AAVAS2666.HKReturn on equity →Price / book →
A bank or insurer earning more on its equity usually trades at a higher multiple of book; points far above the trend are priced for more. Genertec Universal Medical is the large dot.

Capital: ROE delivered against the ROE the price implies

0%10%20%30%0%10%20%30%AIFHOMEFIRST85669678CANFINHOME9941ATLC6033006592FIVESTARZIGSBFCAPTUSWD1905WLFCAAVAS2666.HKROE delivered →ROE the price implies →
Above the diagonal = the price asks for a higher return on equity than the business earns today. Genertec Universal Medical is the large dot.

Genertec Universal Medical competitors and peer comparison

Head to head with its named competitors (2666.HK vs 3360.HK vs 1606.HK vs 1833.HK)
CompanyMarket cap6M returnRevenue growthROEPrice / bookImplied ROE
Genertec Universal Medical 2666.HK$1.18B-16%0%12%0.40×5.2%
Far East Horizon 3360.HK$3.08B-29%+1%8%0.40×4.5%
China Development Bank Financial Leasing 1606.HK$2.59B+3%-5%13%0.39×4.6%
Ping An Healthcare and Technology 1833.HK$1.36B-47%+8%5%0.90×11.2%

How Genertec Universal Medical compares with its peers

Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.

Genertec Universal Medical against its 20 peers (data as of 18 Nov 2026)
Measure2666.HKPeer medianRank in peer set
1-month return+1.3%-0.1%10th highest of 21
6-month return-16.1%-5.1%5th lowest of 21
Return on equity11.6%9.6%9th highest of 21
Price / book0.40×1.29×2nd cheapest of 21
Trailing P/E3.7×12.0×cheapest of 19
ROE the price implies5.2%10.8%7th least demanding of 21
ROE delivered11.6%9.6%9th highest of 21

Peer table

Peer set: Industry: the same industry and sector in any market, nearest in size
CompanyMarketMarket cap6M returnRevenue growthROEPrice / bookImplied ROEDelivered ROE
Genertec Universal Medical 2666.HKHong Kong$1.18B-16%0%12%0.40×5.2%11.6%
Altus AIF.TOCanada$1.18B+17%-11%-1%5.74×30.4%-0.6%
Home First Finance Company India HOMEFIRST.NSIndia$1.20B-1%+19%14%2.40×31.3%14.3%
Ricoh Leasing Company,Ltd 8566.TJapan$1.23B+1%+4%5%0.80×4.6%5.3%
Kanamoto 9678.TJapan$1.25B+17%+2%9%1.23×6.8%9.3%
Can Fin Homes CANFINHOME.NSIndia$1.10B-8%+8%19%1.60×30.2%19.4%
Taiwan Acceptance 9941.TWTaiwan$1.26B-4%-1%12%1.02×3.6%11.7%
Atlanticus ATLCUnited States$1.27B+1%+85%28%1.56×20.4%28.0%
Zhejiang Haikong Nanke Huatie Digital Technology 603300.SSChina$1.28B-33%+12%5%1.24×9.6%5.3%
Hotai Finance 6592.TWTaiwan$1.07B-5%-5%10%0.92×3.3%9.8%
Five-Star Business Finance FIVESTAR.NSIndia$1.35B-6%+9%15%1.59×22.5%15.2%
Zigup ZIG.LUnited Kingdom$1.35B0%+3%7%0.94×12.8%7.1%
SBFC Finance SBFC.NSIndia$1.02B-5%+28%14%2.35×29.5%13.6%
Aptus Value Housing Finance India APTUS.NSIndia$1.01B-26%+18%20%1.73×25.0%20.3%
Walker & Dunlop WDUnited States$1.40B-18%+4%-2%0.82×10.7%-2.0%
Haitong Unitrust International Financial Leasing 1905.HKHong Kong$1.40B+70%-20%6%0.52×4.4%6.5%
Willis Lease Finance WLFCUnited States$980M-28%+22%10%1.34×10.8%10.2%
Jaccs 8584.TJapan$975M-8%+1%5%0.51×4.0%4.8%
Duskin 4665.TJapan$1.42B+23%+3%6%1.45×5.6%6.3%
Sun Hung Kai & 0086.HKHong Kong$970M-7%-11%6%0.34×4.0%6.2%
Aavas Financiers AAVAS.NSIndia$952M-16%+12%14%1.65×24.1%14.0%

Questions

Who are Genertec Universal Medical's main competitors?
Named competitors: Far East Horizon (3360.HK), CDB Financial Leasing (1606.HK), Ping An Healthcare (1833.HK). The cockpit's measured peer set (industry) also includes Altus (AIF.TO), Home First Finance Company India (HOMEFIRST.NS), Ricoh Leasing Company,Ltd (8566.T), Kanamoto (9678.T), Can Fin Homes (CANFINHOME.NS), Taiwan Acceptance (9941.TW).
Is Genertec Universal Medical expensive compared with its peers?
On price / book it trades at 0.40× against a peer median of 1.29×, 2nd cheapest of 21 in its peer set. The share price implies a return on equity of about 5.2%; Genertec Universal Medical delivers 11.6%, so the price asks less than the business earns today.
How has Genertec Universal Medical stock performed?
Over six months to 18 Nov 2026 the shares returned -16.1% against -5.1% for the median peer; over one year -29.6%.

How these numbers are made. Returns are close-to-close in local currency. Revenue growth and margins are trailing twelve months. Req g is the revenue growth that today's enterprise value requires for seven years at the company's own cost of capital; Delivered g is what it actually grew; the gap is the hurdle (honest precision about ±8 points, so read the ranking more than the decimal). No fair values, price targets or analyst ratings are shown, by design. Method and validation.